HARVARD BIOSCIENCE, INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
HARVARD BIOSCIENCE, INC. (HBIO) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-12-31 was $27.00K, a 78.23% decline year-over-year.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-09-30 was $18.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2025 was $99.00K, a 1.00% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2024 was $100.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2023 was -$199.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2021 was $0.00.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $27.00K derived: sum of 3 quarters · filed 2026-08-11 | $45.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $27.00K derived: sum of 2 quarters · filed 2026-05-12 | $45.00K derived: sum of 3 quarters · filed 2026-05-12 | $82.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $45.00K derived: sum of 2 quarters · filed 2026-03-13 | $82.00K derived: sum of 3 quarters · filed 2026-08-11 | $99.00K 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $18.00K 10-Q · filed 2025-11-06 | $55.00K derived: sum of 2 quarters · filed 2026-08-11 | $72.00K 10-Q · filed 2025-11-06 | $196.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $37.00K 10-Q · filed 2026-08-11 | $54.00K 10-Q · filed 2026-08-11 | $178.00K derived: sum of 3 quarters · filed 2026-08-11 | -$79.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $17.00K 10-Q · filed 2026-05-12 | $141.00K derived: sum of 2 quarters · filed 2026-05-12 | -$116.00K derived: sum of 3 quarters · filed 2026-05-12 | -$82.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$133.00K derived: sum of 2 quarters · filed 2026-03-13 | -$99.00K derived: sum of 3 quarters · filed 2026-03-13 | $100.00K 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$257.00K 10-Q · filed 2025-11-06 | -$223.00K derived: sum of 2 quarters · filed 2025-11-06 | -$24.00K 10-Q · filed 2025-11-06 | -$349.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $34.00K 10-Q · filed 2025-08-11 | $233.00K 10-Q · filed 2025-08-11 | -$92.00K derived: sum of 3 quarters · filed 2025-08-11 | $25.00K derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $199.00K 10-Q · filed 2025-05-12 | -$126.00K derived: sum of 2 quarters · filed 2025-05-12 | -$9.00K derived: sum of 3 quarters · filed 2025-05-12 | $440.00K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$208.00K derived: sum of 2 quarters · filed 2025-03-14 | $241.00K derived: sum of 3 quarters · filed 2025-03-14 | -$199.00K 10-K · filed 2025-03-14 | $199.00K 10-K · filed 2024-03-07 | |||
| 2023-09-30 | $117.00K 10-Q · filed 2024-11-08 | $163.00K 10-Q · filed 2023-11-07 | $566.00K derived: sum of 2 quarters · filed 2024-11-08 | $126.00K 10-Q · filed 2024-11-08 | $198.00K 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $449.00K 10-Q · filed 2024-08-08 | $475.00K 10-Q · filed 2023-08-08 | $9.00K 10-Q · filed 2024-08-08 | $35.00K 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | -$440.00K 10-Q · filed 2024-05-07 | |||||||
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 | |||||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $22.00K derived: sum of 2 quarters · filed 2022-03-11 | $21.00K derived: sum of 3 quarters · filed 2022-03-11 | $10.00K derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $21.00K derived: sum of 2 quarters · filed 2022-03-11 | $10.00K derived: sum of 3 quarters · filed 2022-03-11 | -$206.00K 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$1.00K 10-Q · filed 2021-11-05 | -$12.00K derived: sum of 2 quarters · filed 2021-11-05 | -$228.00K 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | -$11.00K 10-Q · filed 2021-08-06 | -$227.00K 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | -$216.00K 10-Q · filed 2021-05-07 | |||||||
| 2019-12-31 | -$572.00K 10-K/A · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |